Etoposide alone and in combination with cyclophosphamide, adriamycin and cis-platinum in patients with Mo and Mi non-small-cell lung cancer

Cancer Treat Rev. 1982 Jun:9 Suppl:119-31. doi: 10.1016/s0305-7372(82)80091-1.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenocarcinoma / drug therapy
  • Antineoplastic Agents / administration & dosage*
  • Cisplatin / administration & dosage
  • Cyclophosphamide / administration & dosage
  • Doxorubicin / administration & dosage
  • Drug Therapy, Combination
  • Etoposide / administration & dosage
  • Etoposide / therapeutic use*
  • Female
  • Humans
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / secondary
  • Male
  • Podophyllotoxin / analogs & derivatives*

Substances

  • Antineoplastic Agents
  • Etoposide
  • Doxorubicin
  • Cyclophosphamide
  • Podophyllotoxin
  • Cisplatin